ROYAL OAK, Mich., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Graphex Technologies, LLC, a wholly owned subsidiary of Graphex Group Limited (collectively "Graphex") (NYSE:GRFX, HKSE: 6128)))) and a global
Gainers
Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares surged 78% to $2.2399 as the stock continued to see momentum despite the company last week announcing it is not aware of any developments that would explain the recent surge.